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Abstract
 
The complement component 
 
C4
 
 genes located in the major histocompatibility complex
(MHC) class III region exhibit an unusually complex pattern of variations in gene number, gene
size, and nucleotide polymorphism. Duplication or deletion of a 
 
C4
 
 gene always concurs with
its neighboring genes serine/threonine nuclear protein kinase 
 
RP
 
, steroid 21-hydroxylase
(
 
CYP21
 
), and tenascin (
 
TNX
 
), which together form a genetic unit termed the RCCX module.
A detailed molecular genetic analysis of 
 
C4A
 
 and 
 
C4B
 
 and RCCX modular arrangements was
correlated with immunochemical studies of C4A and C4B protein polymorphism in 150 nor-
mal Caucasians. The results show that bimodular RCCX has a frequency of 69%, whereas
monomodular and trimodular RCCX structures account for 17.0 and 14.0%, respectively.
Three quarters of 
 
C4
 
 genes harbor the endogenous retrovirus HERV-K(C4). Partial deficien-
cies of C4A and C4B, primarily due to gene deletions and homoexpression of C4A proteins,
have a combined frequency of 31.6%. This is probably the most common variation of gene dos-
age and gene size in human genomes. The seven RCCX physical variants create a great reper-
toire of haplotypes and diploid combinations, and a heterozygosity frequency of 69.4%. This
phenomenon promotes the exchange of genetic information among RCCX constituents that is
important in homogenizing the structural and functional diversities of C4A and C4B proteins.
However, such length variants may cause unequal, interchromosomal crossovers leading to
MHC-associated diseases. An analyses of the RCCX structures in 22 salt-losing, congenital ad-
renal hyperplasia patients revealed a significant increase in the monomodular structure with a
long 
 
C4
 
 gene linked to the pseudogene 
 
CYP21A
 
, and bimodular structures with two 
 
CYP21A
 
,
which are likely generated by recombinations between heterozygous RCCX length variants.
Key words: complement C4 deﬁciency • congenital adrenal hyperplasia • endogenous 
retrovirus • gene dosage • heterozygosity
 
Introduction
 
A distinct feature of the immune system is the drive to
achieve and maintain great diversities. Immunoglobulins
accomplish this goal at the local level in B lymphocytes by
somatic recombination of gene segments and hypermuta-
tions. The MHC class I and class II molecules achieve their
diversities at the germline level, resulting in an enormous
collection of allelic, polymorphic variants within a popula-
tion (1). The variety of the human complement C4 pro-
teins is generated through a complex pattern of genetic dif-
ferences in gene size, gene number, and nucleotide
polymorphisms (for reviews, see references 2, 3).
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Gene Dosage of Complement 
 
C4A
 
 and 
 
C4B
 
 in Caucasians
 
Complement component C4 is an essential component
for the effector arm of the humoral immune response. The
two isotypes C4A and C4B have 
 
.
 
41 variants detectable
by gross differences in electrophoretic mobility (4). C4A
and C4B demonstrate differential chemical reactivities, as
C4A displays higher affinity for amino group–containing
antigens or immune complexes, and C4B for hydroxyl
group–containing antigens (5–8). C4A is generally associ-
ated with the Rodgers (Rg)
 
1
 
 blood group antigens and
C4B, the Chido (Ch) blood group antigens (9–11). The
isotype specificity of C4A and C4B proteins is defined by
four amino acid substitutions at residues 1101–1106, by
which C4A has PCPVLD and C4B has LSPVIH
 
 
 
(11). The
Rg1 and Ch1 are the results of two amino acid substitutions
at residues 1188–1191. The Rg1 epitope has VDLL, and
the Ch1 epitope has ADLR (12), which can be recognized
by mAbs (13). The nucleotide substitutions leading to these
changes are recognizable by restriction fragment length
polymorphisms (RFLPs) in Southern blot analyses (10).
In a haploid genome, there are generally two 
 
C4
 
 genes in
tandem coding for C4A and C4B, but deletions or duplica-
tions of 
 
C4
 
 genes are well documented (14–16). The dele-
tion or duplication of a 
 
C4
 
 gene is always accompanied by
its three neighboring genes: serine/threonine nuclear pro-
tein kinase 
 
RP
 
, steroid 21-hydroxylase 
 
CYP21
 
, and extra-
cellular matrix protein tenascin 
 
TNX
 
. These four genes
form a genetic unit designated as the RCCX module (17,
18). The duplication of RCCX in a bimodular structure
generates an additional gene for complement component
C4, but the other three concurrently duplicated constitu-
ents located between the two 
 
C4
 
 genes are nonfunctional.
Each human 
 
C4 
 
gene contains 41 exons, and the gene size
shows a dichotomous size variation between 21 and 14.6
kb. The long gene is due to the integration of the endoge-
nous retrovirus HERV-K(C4) into intron 9 (19–22). The
frequency of this HERV-K(C4) in the 
 
C4
 
 genes has not
been defined although it appears that this endogenous retro-
virus is always present in the first 
 
C4
 
 locus that usually codes
for a C4A protein. The physiological significance of this
family of endogenous retroviruses has not been elucidated.
The frequency of a partial C4A or C4B protein defi-
ciency in the normal Caucasian population was previously
estimated to be between 25.5 and 33.5% (23). The genetic
etiology may be due to the deletion of a specific 
 
C4A
 
 or
 
C4B
 
 gene (14), the presence of two genes coding for two
identical C4 isotypes or allotypes (10, 24, 25), or the pres-
ence of pseudogenes caused by point mutations (26, 27).
Partial C4 deficiency is the most common immune protein
deficiency in humans. The varying efficiencies of comple-
 
ment activation that results from partial or complete defi-
ciency may have a profound effect on the susceptibility of
an individual to autoimmune diseases. An above average
efficiency may increase the risk of tissue damage in autoim-
munity, and a below average efficiency may slow the disso-
lution and removal of immune aggregates through erythro-
cyte complement receptor CR1 (28). The frequency for
partial C4A deficiency is significantly increased in patients
with the autoimmune disease SLE from different ethnic
groups (29, 30; for a review, see reference 31). Although
the bases for C4 deficiencies in specific individuals have
been elucidated, the causes for the high frequencies of C4A
and C4B null alleles in the normal and in the disease popu-
lations have not been systematically analyzed. An accurate
account of the epidemiology of C4A and C4B deficiencies
and polymorphisms is important for understanding the
roles of complement C4 on autoimmunity. Similarly, elu-
cidation of the RCCX modular variations in the popula-
tion may cast light on the mechanism of pathogenesis for
the disease congenital adrenal hyperplasia (CAH), which
manifests a high range of disease severities from the mild
simple virilizing phenomenon to the life-threatening salt-
losing defects (32).
The presence and the dosage of 
 
C4A
 
 and 
 
C4B
 
 genes to-
gether with three other constituent genes of the RCCX
modules in 150 Caucasians were investigated. The pheno-
types of the C4 proteins were analyzed by immunochemi-
cal experiments. From these analyses, we have uncovered a
high frequency of trimodular RCCX modules (i.e., three
 
C4
 
 genes in a haplotype), elucidated the molecular bases of
C4A and C4B partial deficiencies, and observed a very high
frequency of heterozygosities in length variants of the
RCCX modules. Application of the similar study on pa-
tients with CAH revealed specific patterns of RCCX mod-
ules in the patient population.
 
Materials and Methods
 
Study Populations.
 
The normal group comprised 150 healthy
Caucasian females recruited from central Ohio. None of the vol-
unteers had a personal history or a first to second degree relative
family history of autoimmune disease. The CAH group com-
prised 22 salt-losing CAH patients recruited from the Endocri-
nology Clinics of the Columbus Children’s Hospital, Columbus,
OH. Informed consent from each participant was obtained ac-
cording to approved protocol by the Institutional Human Subject
Review Board of Columbus Children’s Hospital. From each in-
dividual, 10 ml of peripheral blood was taken and EDTA was
added to a final concentration of 1 mM.
 
Isolation of Genomic DNA and Southern Blot Analysis.
 
Geno-
mic DNA was isolated from the blood samples using the Pure-
gene DNA isolation kit (Gentra Systems, Inc.). 8 
 
m
 
g of genomic
DNA was digested to completion with appropriate restriction en-
zymes. Restriction enzymes used included TaqI (GIBCO BRL),
BamHI, PshAI, EcoO109I, and NlaIV (New England Biolabs).
DNA fragments were resolved by electrophoresis of 0.8% agarose
gels except for EcoO109I- and NlaIV-digested DNAs, for which
1.2% gels were used. Southern blot analysis was performed as de-
scribed previously (10, 17).
 
1
 
Abbreviations used in this paper: 
 
CAH, congenital adrenal hyperplasia; Ch,
Chido; CYP21, steroid 21-hydroxylase; L, long, monomodular RCCX
with single long 
 
C4
 
 gene; LL, bimodular RCCX with two long 
 
C4
 
genes; LLL, trimodular RCCX with three long 
 
C4
 
 genes; LS, bimodular
RCCX with one long and one short 
 
C4
 
 gene; LSS, trimodular RCCX
with one long and two short 
 
C4
 
 genes; RCCX, 
 
RP-C4-CYP21-TNX
 
;
RFLP, restriction fragment length polymorphism; Rg, Rodgers; RP,
serine/threonine nuclear protein kinase; S, short, monomodular RCCX
with single short 
 
C4
 
 gene; TNX, tenascin. 
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DNA Probes.
 
The positions of the genomic DNA in the
MHC complement gene cluster (MCGC) to which the probes
hybridized are illustrated in Fig. 1. The DNA fragments for
probes A and C were derived from cloned DNA fragments in
plasmids; the others were generated by PCR using the appropri-
ate primers and DNA templates. The probes were as follows:
probe A, a 1.1-kb cDNA fragment of 
 
RP1
 
, or a 600-bp NheI-
EcoRI fragment corresponding to the 3
 
9
 
 end of the DNA se-
quence present in both 
 
RP1
 
 and 
 
RP2
 
; probe B, a 0.8-kb fragment
corresponding to exons 6–9 of the 
 
C4 
 
gene, amplified by PCR
using 
 
E65 
 
and 
 
E93 
 
as primers and 
 
cos
 
 3A3 as template; probe C,
also referred to as P
 
B
 
, a 926-bp BamHI fragment of the C4d re-
gion from 
 
l
 
JM-2a; probe D, a 1.1-kb fragment corresponding to
exons 28–31of 
 
C4
 
, amplified by primers 
 
E285
 
 and 
 
E313
 
 and 
 
cos
 
3A3 as template; probe E, a 757-bp fragment corresponding to
exons 4–7 of 
 
CYP21
 
, amplified from cosmid DNA 
 
cos
 
 4A3, using
primers 
 
21A5
 
 and 
 
21A3
 
; and probe F, a 500-bp fragment corre-
sponding to exons 35–37 of 
 
TNXA
 
, amplified using primers
 
RDX-5
 
 and 
 
RDX-3 
 
and 
 
cos
 
 4A3 as the DNA template (17, 33).
 
Complement C4 Allotyping and Immunoblot Analysis.
 
Periph-
eral blood plasma from EDTA samples was used to test for allo-
typic polymorphisms of complement C4 following standard pro-
cedures (34–36). Some of the C4A and C4B phenotypes were
confirmed with Western immunoblot analysis using anti-Ch1
and anti-Rg1 mAbs (anti-C4B; a gift from Dr. Joann Moulds,
University of Texas, Houston, TX) at a dilution of 1:5,000 and
1:1,000, respectively. Immune complexes were detected by the
chemiluminescence method using ECL Plus reagents (Amersham
Pharmacia Biotech).
 
Detection of C4 Mutants.
 
Sequence-specific PCRs were used
to detect the known C4 mutations in samples whose C4 protein
products could not be appropriately accounted for. The PCR
primers for detection of the 2-bp insertion in exon 29 were: (A-
down) AGG ACC CCT GTC CAG TGT TAG AC, (B-down)
AGGACCTCTCTCCAGTGATACAT, and (E29-INS) GCT
CTG AGA ACC AGT GAC TAG AG. PCR conditions were 1
cycle at 94
 
8
 
C for 5 min; 25 cycles at 94
 
8
 
C for 30 s, 65
 
8
 
C for 45 s,
and 72
 
8
 
C for 1 min; and 1 cycle at 72
 
8
 
C for 10 min.
 
Results
 
An intensive study of the molecular organization of
RCCX modular structure and the genotype and pheno-
type of complement component C4 was performed. Defin-
itive RFLPs were applied to detect and distinguish the
number of RCCX modules present on each chromosome
6, the length polymorphism of the 
 
C4
 
 genes, the identity
of C4A and C4B isotypes, and the association with the ma-
 
jor antigenic determinants of the Rg1 and Ch1 blood
group. The phenotypes of complement component C4
were examined by immunofixation of EDTA-blood
plasma. The antigenic determinants of the C4A and C4B
proteins were determined by immunoblot analysis using
anti-Rg1 and anti-Ch1 mAbs. The genotypic and pheno-
typic data were then analyzed together to interpret the
RCCX and the probable C4 haplotypes of each individual.
 
Patterns of RCCX Variations in Selected Individuals
 
12 samples were selected from the study population to
exemplify the complexity of the RCCX modular variations
and the corresponding genotypes and phenotypes of C4
(Fig. 2). A descriptive summary of these subjects is pro-
vided in Table I. In brief, these samples can be categorized
into five groups.
 
Bimodular RCCX Haplotypes with Both C4A and C4B
Proteins.
 
The genotype and phenotype of C006 are de-
scribed in detail to illustrate the complex analysis of the
data. In Fig. 2, panel I-A, the TaqI Southern blot demon-
strates equal band intensities for the 7.0-kb fragment corre-
sponding to 
 
RP1-C4L
 
 and the 6.0-kb fragment corre-
sponding to 
 
RP2
 
-
 
C4L
 
.
 
 
 
In addition, the relative band
intensities for the 3.7-kb fragment for 
 
CYP21B
 
 and the
3.2-kb fragment for 
 
CYP21A
 
, as well as the 2.5-kb frag-
ment for 
 
TNXB
 
 and 2.4-kb fragment for 
 
TNXA
 
, are equal.
These data suggest a homozygous, bimodular haplotype of
 
RP1-C4L-CYP21A-TNXA-RP2-C4L-CYP21B-TNXB
 
,
abbreviated LL/LL. Confirmation of the bimodular struc-
ture is provided by the BamHI RFLP (panel I-B) demon-
strating equal intensities of the 6.5-kb band for 
 
TNXB
 
 and
the 4.9-kb band BamHI band for 
 
TNXA
 
.
In panel II-A, the PshAI Southern blot differentiates iso-
type 
 
C4A (4.35-kb fragment) from C4B (8.2-kb fragment).
The respective bands in C006 are of similar intensities, re-
flecting the presence of both isotypes to the same degree.
EcoO109I (panel II-B) defines the genotype based on asso-
ciation with C4-Rg1 (565-bp fragment) and C4-Ch1
(458-bp fragment). The C4 allotyping and immunoblot
analyses reveal that C006 has equal protein expression of
C4A3 and C4B1 (panel III-A), which are associated with
Rg1 and Ch1 epitopes (panel III-B), respectively. The bi-
modular LL/LL structure suggests that C006 has two C4
genes on each chromosome 6, and the possible C4 haplo-
types are C4A3 B1/C4A3 B1 or C4A3 A3/C4B1 B1.
Figure 1. A schematic diagram of the hu-
man MHC complement gene cluster. The
functional genes of the RCCX modules are
highlighted. A horizontal arrow represents
the transcriptional orientation of a gene;
vertical arrows represent locations of the
DNA hybridized to probes A–F. K(C4), en-
dogenous retrovirus HERV-K(C4); 21A,
CYP21A; 21B, CYP21B; XA, TNXA.2186 Gene Dosage of Complement C4A and C4B in Caucasians
Based on the presumption that within a bimodular RCCX
structure with equal quantities of C4A and C4B genes and
proteins, the first C4 locus codes for C4A and the second
C4 locus codes for C4B, C006 is assigned a probable hap-
lotype of C4A3 B1/C4A3 B1.
Patient C019 is assigned bimodular, LL/LS. This assign-
ment is based on the presence of a 7.0-kb TaqI fragment
(RP1-C4L), a 6.0-kb fragment (RP2-C4L), and a 5.4-kb
fragment (RP2-C4S), with a band intensity for the 7.0 kb
fragment that is two times that of the 6.0- and 5.4-kb frag-
ments (panel I-A, lane 2). Band intensities for TNXA and
B and for CYP21A and B on the TaqI digest and for
TNXA and B on the BamHI digest are similar, confirming
a bimodular/bimodular structure as in C006. C019 has C4
allotypes A4, A6, B1, and B1 (lane 2) and her haplotypes
are assigned C4A4 B1/C4A6 B1. The C4A and C4B pro-
teins have the expected association with the Rg1 epitope
and the Ch1 epitope, respectively.
For patient C144, TaqI and BamHI RFLPs suggest that
she has a homozygous LS/LS RCCX modular structure.
The PshAI Southern blot demonstrates an equal number of
C4A and C4B genes (panel II-A, lane 3). However, the
EcoO109I blot for Rg1 and Ch1 of the C4 genes reveals a
ratio of 1:3 (panel II-B, lane 3), suggesting that one of the
C4A proteins is associated with Ch1. The C4 allotyping
data confirmed three C4 proteins reacting with the Ch1
mAb: C4A12, B1, and B2. The C4 allotype reacting with
Rg1 mAb is C4A4. The predictive haplotypes for C144 are
C4A12 B1/C4A4 B2 or C4A12 B2/C4A4 B1.
These four individuals (C006, C088, C019, and C144)
each have a bimodular/bimodular RCCX structure con-
taining four C4 genes in each diploid genome. The C4
gene in the first locus is always long. The C4 gene in the
second locus is either long or short. These C4 genes en-
code for both isotypes of C4 protein, C4A and C4B.
Individuals with Complete or Partial C4A Protein Deficiency
(C4AQ0 Phenotypes). The next group of individuals (Fig.
2, lanes 4–6) all demonstrate complete (C071 and C040) or
partial (C098) deficiency of C4A protein, verified on the
C4 allotyping and immunoblot experiments (panels III-A
and III-B). Each of these individuals demonstrates the pres-
ence of a 6.4-kb fragment on the TaqI RFLP, correspond-
ing to a monomodular RCCX structure with a single short
C4B gene linked to RP1, or RP1-C4B-CYP21B-TNXB.
C071 has this haplotype on both of her chromosomes, and
absence of C4A, CYP21A, TNXA, and RP2 (lane 4). Her
genotype data based on PshAI and EcoO109I RFLPs dem-
onstrate the absence of C4A genes and C4 genes associated
with Rg1 (panels II-A and II-B). The allotype gel confirms
the absence of C4A protein expression (panel III-A). RFLP
analysis of C040 and C098 with TaqI reveals a bimodular
RCCX structure with 7.0- and 6.0-kb fragments consis-
tent with the bimodular RP1-C4L-CYP21A-TNXA-RP2-
C4S-CYP21B-TNXB (abbreviated LS) in addition to the
Figure 2. Genotypic and phenotypic analyses of
the RCCX modules in selected individuals. (I)
TaqI and BamHI RFLPs, to define the RCCX
modular structure of each chromosome. Probes A,
E, and F were used for TaqI RFLP; probe E was
used for BamHI RFLP. (II) Detection of the C4A
and C4B genes and C4 genes associated with Rg1
or Ch1 by PshAI (A) and EcoO109 (B) RFLPs
with probes C and D, respectively. (III) Detection
of C4A and C4B allotypes by immunofixation (A)
and immunoblot analysis (B), respectively. T, tri-
modular; C, CAH carrier.2187 Blanchong et al.
6.4-kb fragment mentioned above. C4 genotyping in pan-
els II-A and II-B demonstrates the presence of C4A and
C4B genes and their associations with Rg1 and Ch1, re-
spectively. However, the allotyping experiment shows no
C4A protein detectable in C040 (panel III-A, lane 5). Se-
quence-specific PCR revealed that C040 has a C4A mu-
tant gene characterized by a 2-bp insertion in codon 1213
of exon 29 (data not shown).
Therefore, the deficiency of C4A proteins, as demon-
strated in these three individuals, may be caused by the
presence of a monomodular RCCX structure with the ab-
sence of a C4A gene (gene deletion), or by the presence of
a C4A pseudogene (as in C040).
Individuals with Complete or Partial C4B Protein Deficiency
(C4BQ0 Phenotypes). C4 allotyping and immunoblot ex-
periments of the next group consist of three individuals
(lanes 7–9) who demonstrate a complete (C020) or a partial
(C106 and C015) deficiency of C4B. The modular struc-
tures of C020, as shown by TaqI and BamHI RFLPs (panel
I, lane 7), are bimodular LL/bimodular LL, which imply
the presence of four C4 genes. However, no C4B genes
are detectable on PshAI RFLP and no Ch1-associated C4
genes are present in the EcoO109I blot. Allotyping experi-
ments suggested that all four C4 genes in C020 result in
production of C4A proteins A3, A2, A2, and A5 (panel III,
lane 7). In other words, the complete C4B deficiency in
C020 is due to all four C4 gene loci from the bimodular/
bimodular RCCX haplotypes encoding for C4A proteins.
TaqI and BamHI RFLPs reveal that in C106, the restric-
tion fragments for RP1-C4(L), CYP21B, and TNXB are
two times more intense than those for RP2-C4(L),
CYP21A, and TNXA (panels I-A and I-B, lane 8). There-
fore, C106 has the heterozygous bimodular LL and mono-
modular L haplotypes. The PshAI RFLP reveals that there
are two C4A genes and one C4B gene. The EcoO109I
RFLP shows that there are two C4 genes associated with
Rg1 and one C4 gene associated with Ch1. The allotyping
and immunoblot experiments reveal a corresponding 2:1
ratio for C4A3-Rg1 and C4B1-Ch1. The partial C4B defi-
ciency is due to the deletion of a C4B gene associated with
a monomodular structure.
The TaqI and BamHI RFLPs revealed that C015 has the
LL/LS RCCX structures. However, PshAI and EcoO109I
RFLPs revealed three C4A or Rg1-associated genes, and
one C4B or Ch1-associated gene (panel II, lane 9). C4 al-
lotyping and immunoblot experiment revealed a 3:1 ratio
for C4A3-Rg1 and C4B6-Ch1. Therefore, C015 is as-
signed C4A3 A3/C4A3 B6. The apparent partial C4B de-
Table I. Relative Gene Dosage of the RCCX Modules from Selected Individuals
TaqI BamHI PshAI EcoO109I*
RP-C4‡ 21B 21A XB XA XB XA C4B C4A Rg1 Ch1
RCCX
modules Probable C4 haplotypes
7.0 6.4 6.0 5.4 3.7 3.2 2.5 2.4 6.5 4.9 8.2 4.35 565 457
I
1. C006 2§ 0 2 0 2 2 2 2 2 2 2 2 2 2 LL/LL A3 B1/A3 B1
2. C019 2011 2 2 222 2 2 2 2 2 LL/LS A4 B1/A6 B1
3. C144 2002 2 2 222 2 2 2 1 3 LS/LS A4 B2/A12 (Ch1) B1
II
4. C071 0200 2 0 202 0 2 0 0 2 S / S AQ0 B1/AQ0 B1
5. C040 1101 2 1 212 1 2 1 1 2 LS/S AQ0 B2/AQ0 B1
6. C098 1101 2 1 212 1 2 1 1 2 LS/S A3 B1/AQ0 B1
III
7. C020 2020 2 2 222 2 0 4 4 0 LL/LL A3 A2/A2 A5
8. C106 2010 2 1 212 1 1 2 2 1 LL/L A3 B3/A3 BQ0
9. C015 2011 2 2 222 2 1 3 3 1 LL/LS A3 A3/A3 B6
IV
10. C007 2021 2 3 232 3 2 3 3 2 LLL/LS A3 A3 B1/A3 B1
11. C097 2040 2 4 242 4 2 4 4 2LLL/LLL A3 A3 B1/A3 A3 B1
V
12. C046 1100 1 1 202 0 1 1 0 2 L / S A 1   (Ch1) BQ0/AQ0 B1
21A, CYP21A; 21B, CYP21B; XA, TNXA; XB, TNXB.
*Restriction fragment size in bp.
‡RP1-C4(L), 7 kb; RP1-C4(S), 6.4 kb; RP2-C4(L), 6 kb; RP2-C4(S), 5.4 kb (sizes of all fragments in kb except for EcoO109I).
§Relative gene dosage.2188 Gene Dosage of Complement C4A and C4B in Caucasians
ficiency is due to the expression of two C4A3 allotypes
from one of the chromosome 6.
Trimodular RCCX Structures. Phenotypic studies of C4
on C007 and C097 show a significant higher expression of
C4A3-Rg1 than C4B1-Ch1 (Fig. 2, panel III, lanes 10 and
11). However, RFLP studies for the RCCX and C4 geno-
types do not suggest any monomodular RCCX structures
in these individuals.
On the TaqI RFLP, C007 demonstrates a 7.0-kb frag-
ment corresponding to RP1-C4L, a 6.0-kb fragment corre-
sponding to RP2-C4L, and a 5.4-kb fragment correspond-
ing to RP2-C4S. These three TaqI fragments appear to
have a ratio of 2:2:1. Differential gene dosages of CYP21
and TNX are demonstrated, as the 3.2-kb fragment for
CYP21A is more intense than the 3.7-kb CYP21B, and the
2.4-kb TNXA is greater than 2.5-kb TNXB. In addition,
the 5.0-kb BamHI fragment for TNXA and the 6.5-kb
fragment for TNXB have a ratio of z3:2 (panel I-B, lane
10). Genotyping of C4 revealed that C007 has more C4A
and Rg1-associated genes than C4B or Ch1-associated
genes (Fig. 2, panels II-A and II-B, lane 10). As there are
two RP1 and two TNXB genes in every individual, the
higher gene dosages of RP2 and TNXA suggest that one of
the chromosome 6 has a trimodular RCCX structure with
three long C4 genes. The presumed RCCX haplotypes for
C007 are trimodular RP1-C4A3(L)-CYP21A-TNXA-
RP2-C4A3(L)-CYP21A-TNXA-RP2-C4B1(L)-CYP21A-
TNXB  and bimodular RP1-C4A3(L)-CYP21A-TNXA-
RP2-C4B1(S)-CYP21B-TNXB.
Results of the RFLP studies for C097 reveal homozy-
gous trimodular structures LLL/LLL. The 6.0-kb RP2-C4L
fragments are two times more intense than the 7.0-kb RP1-
C4L fragments. In addition, the band intensities for frag-
ments corresponding to CYP21A and TNXA both have
2:1 ratios over their corresponding CYP21B and TNXB.
Since the C4A or Rg1-associated genes are higher in dos-
ages than the C4B or Ch1-associated genes, the C4 haplo-
types of C097 are assigned C4A3 A3 B1/C4A3 A3 B1.
Unusual RCCX Patterns. C046 demonstrates two C4
genes by the presence of the 7.0- and 6.4-kb TaqI frag-
ments, indicating a monomodular L and a monomodular S
structure, respectively (panel I, lane 12). The TaqI and
BamHI RFLPs show the absence of TNXA-RP2 gene seg-
ments but the presence of a CYP21A and a CYP21B. On
one chromosome there is a deletion of TNXA-RP2-C4B-
CYP21B; on the other chromosome there is a deletion of
C4A-CYP21A-TNXA-RP2. This individual is a carrier of
CAH because of the CYP21B gene deletion. Another in-
teresting point is the PshAI RFLP reveals that both C4A
and C4B genes are present (panel II-A, lane 12), but on
the EcoO109I blot, both C4 genes are associated with
Ch1 (panel II-B, lane 12). The allotyping gel and immu-
noblot experiments confirmed the presence of two C4
proteins expressing the Ch1 epitope. The predicted C4
haplotypes are AQ0 B1/A1 BQ0. Similar to the C4A12 in
C0144, C4A1 has the reverse association with Ch1. The
C4AQ0 or C4BQ0 in each case is due to the deletion of
an RCCX module.
RCCX Modular Variations in the Normal Caucasian Population
The study population with 150 normal Caucasian fe-
males was analyzed as described above. From the extensive
RFLP experiments, C4 allotyping and immunoblot analy-
ses, the frequencies of the long and short C4 genes, the
monomodular, bimodular, and trimodular RCCX struc-
tures in haplotypes and in diploids, and the bases of the
C4A and C4B deficiencies are determined.
Long and Short C4 Genes. The presence of the long and
short C4 genes is determined by two independent RFLP
experiments. From the TaqI Southern blots, the long C4
genes are designated with the 7.0- and 6.0-kb fragments,
the short C4 genes with the 6.4- and 5.4-kb fragments.
From the BamHI Southern blots hybridized with probe B
(Fig. 1), the long C4 genes are indicated by the presence of
the 4.8-kb fragments and the short C4 genes by the 3.3-kb
fragments (data not shown). Among the 590 complement
C4 genes present in the study population, there are 450
(76.2%) long genes and 140 (23.7%) short genes. This result
implies that 3/4 of the population has the endogenous ret-
rovirus HERV-K(C4) in their C4 genes and 1/4 does not
(Table II).
RCCX Modules. The presence of a bimodular RCCX
haplotype is determined by the concurrent presence and
the equimolar ratio of the RP1-C4(L) (7.0 kb) with the
RP2-C4(L) (6.0 kb) (i.e., LL), or the RP2-C4(S) (5.4 kb)
fragments (i.e., LS) in the TaqI RFLP. It is also indicated
Table II. Genotypes and Phenotypes of Complement C4A and 
C4B in the Normal Caucasian Population
C4 genotypes
No. of individuals studied 150
(No. of chromosome 6) (300)
Total no. of C4 genes present 590
Frequency of long C4 genes 76.2%
Frequency of short C4 genes 23.7%
Phenotypes of C4A and C4B
Allotype n Percent* Allotype n Percent*
A1 1 0.17 B1 236 40.1
A12 1 0.17 B13 1 0.17
A2 17 2.89 B2 25 4.25
A3 274 46.6 B3 2 0.34
A4 11 1.87 B6 2 0.34
A5 3 0.51
A6 15 2.55
Total 322 54.8 Total 266 45.2
*Frequency among all C4 allotypes.2189 Blanchong et al.
by the concurrent presence of a 4.9-kb TNXA fragment
and a 6.5-kb TNXB fragment in the BamHI RFLP. Fur-
ther supporting data include but are not limited to the
equal intensities of the restriction fragments for CYP21A
and CYP21B, and/or for C4A and C4B, C4-Rg1 and C4-
Ch1. Among the 300 copies of chromosome 6 (or haplo-
types) investigated, there are 138 (46.0%) chromosomes
with a bimodular LL haplotype and 69 (23%) chromosomes
with a bimodular LS haplotype. Altogether, 69.0% of the
chromosome 6 are bimodular in RCCX structures.
The presence of a monomodular RCCX structure with
a single short C4 gene is demonstrated by the presence of a
6.4-kb fragment for RP1-C4(S) accompanied by a copy of
CYP21B (3.7 kb) and a copy of TNXB (2.5 kb). The pres-
ence of a monomodular RCCX structure with a long C4
gene is demonstrated by the presence of the 7.0-kb RP1-
C4(L) and the absence of the 6.0-kb RP2-C4(L) or the
5.4-kb RP2-C4(S) in a TaqI RFLP, and the absence of
4.9-kb TNXA and RP2 in a BamHI RFLP. In the study
population, there are 33 (11%) monomodular short chro-
mosomes and 18 (6%) monomodular long chromosomes.
Together, the two monomodular RCCX haplotypes have
a frequency of 17%.
In contrast to the monomodular RCCX haplotypes, the
trimodular structure is defined by relatively higher intensi-
ties of the restriction fragments for RP2-C4(L) and/or RP-
C4(S) compared with that for the RP1-C4(L) in a TaqI
RFLP. Similarly, the ratio of RP1 to RP2 and of TNXB to
TNXA is ,1:1 in a BamHI RFLP. In the study popula-
tion, 19 (6.33%) chromosomes are LSS, 22 (7.33%) chro-
mosomes are LLL, and 1 (0.33%) is LLS (or LSL). As
shown in Fig. 3, seven RCCX length variants, LL, LS, L,
S, LLL, LSS, and LLS, are detectable. These 7 modular
structures give rise to 20 different haplotypes of RP, C4,
CYP21, and TNX genes.
Diploid RCCX Combinations. The various combina-
tions of RCCX haplotypes in diploids are shown in Fig. 4
(A and C). In brief, the most common combination is bi-
modular/bimodular (B/B), as it is present in 48% of the
study population. The frequencies for monomodular/bimod-
ular (M/B) and the bimodular/trimodular (B/T) com-
binations are 25.3 and 17.3%, respectively. Homozygous
Figure 3. The frequencies and structures
of RCCX modules in the normal Cauca-
sian population. The most common haplo-
types are in bold. L, long C4 gene; S, short
C4 genes.2190 Gene Dosage of Complement C4A and C4B in Caucasians
monomodular (M/M) and homozygous trimodular (T/T)
combinations are less frequent, equaling 2.0 and 3.3%, re-
spectively (Fig. 4 A).
Altogether, 17 different diploid combinations of the
RCCX structures were detected in the normal population.
Among them, LL/LS and LL/LL are most frequent, with
20.7 and 19.3%, respectively. The third most prevalent
diploid is LL/S, with a frequency of 12.0%. The other 13
diploid combinations have frequencies varying between
0.67 and 8.67% (Fig. 4 C).
It is notable that within the combinations, 90.4% of indi-
viduals have at least one chromosome with a bimodular
structure. From another view, 31.3% have at least one chro-
mosome with a monomodular structure, and 24.6% have at
least one chromosome with a trimodular structure. In total,
69.4% of the diploid genomes have heterozygous combina-
tions of RCCX modules that differ in length by the num-
ber of RCCX modules and/or the size of the C4 genes.
Number of C4 Genes. The frequency of C4 gene dos-
age variation is shown in Fig. 4 B. Most individuals have
four C4 genes (frequency 52.0%) that may be the result of
bimodular/bimodular (B/B) or monomodular/trimodular
(M/T) diploids. Individuals with three C4 genes in a ge-
nome, which are due to the presence of monomodular/
bimodular (M/B) combinations, comprise 25.3% of the
normal population. Individuals with bimodular/trimodular
(B/T) structures have five C4 genes in a genome. They ac-
count for 17.3% of the population. An individual with tri-
modular/trimodular (T/T) structures has six C4 genes,
which has a frequency of 3.3%. Only three subjects are
found with monomodular/monomodular (M/M) struc-
tures, or two C4 genes in a diploid genome, which trans-
lates to a frequency of 2.0%.
The Phenotypes and Genotypes of the Complement Components 
C4A and C4B
Of the 590 C4 genes present in the normal study popu-
lation, 322 (54.8%) genes encode for the C4A isotype and
275 (45.2%) encode for the C4B isotype. A total of 588 ex-
pressed C4 allotypes with considerable polymorphisms
were detected. As expected, the allotypes C4A3 and C4B1
are the most common, consisting of 46.6 and 40.1% of the
C4 allotypes, respectively. The frequencies of the various
C4A and C4B allotypes are listed in Table III.
The Molecular Bases of the C4BQ0 Phenotype. A distinct
population with the bimodular structures carries two iden-
tical C4 isotypic genes on the same chromosome, that is,
both C4 genes encode for the C4A (or for the C4B) pro-
Figure 4. Diploid combinations of the RCCX
modules in the Caucasian population. (A) Frequen-
cies of RCCX modular combinations based on the
number of modules. (B) Variations in the number
of C4 genes. (C) Frequencies of the RCCX mod-
ules based on the number of modules and size of
C4 genes.2191 Blanchong et al.
teins. This combination leads to a C4BQ0 (or C4AQ0)
phenotype (Table III). Such a phenomenon contributing to
C4BQ0 phenotype is confirmed by the presence of the
C4A genes using PshAI (or NlaIV) RFLP and the C4-Rg1
using EcoO109I RFLP, and relatively higher intensities of
the C4A proteins in allotyping gels and in immunoblots
compared with those for C4B and C4-Ch1. This C4A-
C4A homoexpression pattern consists of 13.3% of the
RCCX haplotypes in the study population. Specifically,
10% of the RCCX haplotypes encode C4A3, C4A3,
2.27% encode C4A3, C4A2. Two individuals (0.67%) ap-
pear to contain bimodular RCCX haplotypes coding for
C4A3, C4A6 and for C4A4, C4A5, respectively.
Another cause for the C4BQ0 phenotype is due to the
presence of monomodular L structure with a single C4A
gene. This RCCX structure has a frequency of 5.0%. No
C4B mutant gene has been detected in this study popula-
tion. Therefore, the C4BQ0 phenotype has a combined
frequency of 18.3%.
The Molecular Bases of the C4AQ0 Phenotype. 11% of
the haplotypes in the study population have monomodular
S chromosomes and all of them appear to code for the
C4B1 allotype. In addition, 1% of the haplotypes has a
monomodular L chromosomes with single C4B genes.
Homoexpression of C4B proteins from bimodular RCCX
structures is present at a frequency of 0.67%; the same fre-
quency is observed for the presence of C4A mutant genes
with a 2-bp insertion in exon 29. Therefore, the combined
frequency of the C4AQ0 phenotype is 13.3% (Table IV).
Together, the partial and complete C4AQ0 and C4BQ0
phenotypes (or deficiencies) have a combined frequency of
31.6% in the normal population. Complete C4A deficiency
is only found in one individual, who has homozygous
monomodular S (C071; Fig. 2). Complete C4B deficien-
cies are only found in two individuals, of whom one has
homoexpression of C4A proteins from both chromosomes
(C020; Fig. 2) and the other has heterozygous RCCX hap-
lotypes with C4A homoexpression from the bimodular
structure and the presence of a single C4A gene from the
monomodular L structure (C033; data not shown).
C4 and CYP21 Genes in RCCX Trimodular Haplotypes.
As listed in Table IV, 42 trimodular haplotypes were de-
tected in the normal subjects. Overall, 7.33% of the
RCCX haplotypes contain two C4A and one C4B gene,
and 6.67% contain one C4A and two C4B genes. The LLL
structures more frequently code for C4A-C4A-C4B,
whereas the LSS structures more frequently code for C4A-
C4B-C4B.
In the same population, the CYP21A-CYP21A-CYP21B
configuration was found in 37 haplotypes (12.3%), and the
CYP21A-CYP21B-CYP21B configuration was found in
5 haplotypes (1.67%). In other words, 88.1% of the tri-
modular chromosomes have two CYP21A genes and one
CYP21B gene.
RCCX Structures and CYP21 Genes in Patients with
Classical CAH
Among the 150 normal subjects, two individuals have a
heterozygous deletion of the CYP21B gene in RCCX
monomodular structures (frequency in haplotypes 0.67%).
In addition, four individuals have two CYP21A genes from
the bimodular RCCX haplotypes (frequency 1.33%). These
six individuals are carriers of the classical form of CAH.
As an example to illustrate the impact of RCCX modu-
lar variations in MHC-associated diseases, we studied the
22 patients with the classical salt-losing form of CAH. The
results are listed in Table V. Seven typical diploid combina-
tions of the RCCX structures from the CAH patients are
shown in Fig. 5.
Monomodular, bimodular, and trimodular RCCX
structures are detectable in the CAH population. However,
monomodular structures with a long C4 gene (mono-L)
with the presence of CYP21A (i.e., deletion of CYP21B;
Fig. 5, lanes 1 and 2) have a haplotype frequency of 20.5%
(P , 0.001). Gene conversions with two CYP21A pseudo-
Table III. Molecular Bases for Partial Deficiencies of C4A and 
C4B in the Normal Caucasian Population
C4AQ0 C4BQ0 Total
n Percent* n Percent* n Percent*
Gene deletion 36 12 15 5. 51 17
Mono-L 3 1.0 15 5.0 18 6
Mono-S 33 11.0 0 0 33 11
Gene mutation 2 0.67 0 0 2 0.67
Gene conversion 2 0.67 40 13.3 42 14.0
C4A-C4A (40) (13.3)
A3-A3 (30) (10.0)
A3-A2 (8) (2.67)
Others (2) (0.67)
C4B-C4B (2) (0.67)
Total 40 13.3 55 18.3 95 31.6
*Frequency in haplotypes.
Table IV. C4A and C4B Genes in Trimodular
RCCX Structures
C4A-C4A-C4B C4A-C4B-C4B
n Percent* n Percent*
LLL 14 4.67 8 2.67
LSS 7 2.33 12 4.0
LLS 1 0.33 0 0
Total 22 7.33 20 6.67
*Frequency in haplotypes.2192 Gene Dosage of Complement C4A and C4B in Caucasians
sian population, the frequency for the half-null allele for
C4A was 9.5–14.5%, and the frequency for the half-null al-
lele of C4B was 16–19%. “Homoduplication” of C4A or
C4B, defined as the presence of three C4 genes or two C4
genes coding for the same C4A or C4B isotypes, was 1–2%
(23). The current study firmly establishes a “1-2-3 loci”
concept for C4 and CYP21 in the Caucasian population.
We have observed an apparent, partial C4A deficiency at a
frequency of 13.3% and partial C4B deficiency at a fre-
quency of 18.3%. This extremely high degree of apparent,
partial protein deficiencies in the population is predomi-
nantly the result of the presence of monomodular structures
and homoexpression of identical C4A or C4B isotypes from
bimodular structures. The C4A mutant gene due to the
2-bp insertion in codon 1213 (in exon 29) was detected in
only two individuals of the normal study population.
The frequency of three C4 gene haplotypes (or trimodu-
lar RCCX structures) was underestimated in previous stud-
ies. As stated above, we identified that 14.0% of the
RCCX structures in chromosome 6 are trimodular. The
trimodular structures are predominantly present as LLL and
LSS; the former more frequently codes for C4A3-A3-B1,
and the latter, C4A3-B1-B1. These trimodular configura-
Table V. RCCX Structures, CYP21A and CYP21B Genes in 
Patients with Classical CAH
Patients
(n 5 44)
Normal subjects
(n 5 300)
RCCX n Percent* n Percent* P
Mono-L 11 25.0 18 6.0 ,0.001
Mono-S 0 0 33 11.0 ,0.001
LL 16 36.4 138 46.0
LS 13 29.5 70 23.3 0.23
LLL 2 4.5 21 7.0 0.368
LSS 2 4.5 19 6.33
CYP21A in mono-L 9 20.5 2 0.67 ,0.001
CYP21A-CYP21A 11 22.7 4 1.33 ,0.001
CYP21A-CYP21A-CYP21B 4 9.1 37 12.3
CYP21A-CYP21B-CYP21B 0 0 5 1.67
Number of CAH patients studied: 22 (number of chromosome 6: 44);
total number of C4 genes detectable: 81; frequency of long C4 genes:
79.0% (normal 76.2%); frequency of short C4 genes: 21% (normal
23.7%).
*Frequency in haplotypes.
Figure 5. RCCX modular variations in classical CAH patients. (A)
TaqI RFLP on seven selected CAH patients to show the RCCX diploid
combinations. The 8-digit number above each lane represents the relative
dosage of the 7.0-, 6.4-, 6.0-, and 5.4-kb fragments for RP-C4, and the
3.7-, 3.2-, 2.5-, and 2.4-kb fragments for CYP21B, CYP21A, TNXB,
and TNXA, respectively, as shown in Table I. (B) PshAI RFLP to deter-
mine the C4A and C4B gene dosage in the corresponding patients. (C)
Interpretation of the RCCX structures and the relative gene dosage of
CYP21A and CYP21B, and of C4A and C4B.
genes from bimodular RCCX structures (Fig. 5, lanes 4
and 6) account for 22.7% of the disease haplotypes. Over-
all, 43.2% of the RCCX haplotypes in the CAH popula-
tion do not contain a CYP21B gene. Compared with the
normal group, the CAH population has a striking increase
of monomodular RCCX with a long C4 gene (25 vs. 6%;
P  ,  0.001) and a total absence of the monomodular
RCCX with a short C4 gene (mono-S).
Discussion
The high frequency and complexity of complement
component  C4 gene size, number, and modular variations
with flanking genes RP, CYP21, and TNX in the Cauca-
sian population are described. The RCCX modules were
investigated through genetic analysis using six different
probes for diagnostic RFLP analyses to define genomic
structures including the number and size of genes, the pres-
ence of C4A versus C4B, and the association of the C4
genes with Rg1 and Ch1 antigenic determinants. Com-
bined with protein allotyping data, accurate assignments of
genotype–phenotype relationships were made. The etiol-
ogy of C4 null alleles through gene deletion, gene duplica-
tion, and mutant genes was defined.
The number of C4 gene loci present in humans was a
controversial topic until O’Neill et al. (37), Awdeh and
Alper (35), and Rittner and colleagues (38) proposed a two-
loci theory with C4A and C4B genes. Thereafter, individu-
als with one or three C4 genes have been documented,
which were largely presumed to be caused by secondary
gene deletions and gene duplications (14, 16, 39). Based on
C4 protein typing data, it was estimated that in the Cauca-2193 Blanchong et al.
tions would manifest the false, partial C4A or C4B defi-
ciency phenotypes in C4 allotyping gels if not coupled
with a systematic analysis of the RCCX genomic struc-
tures. In other words, the protein allotyping data alone are
not enough to define the etiologic mechanisms behind re-
lationships between complement C4A or C4B deficiency
and autoimmune disease. To understand the relationship of
C4A and C4B polymorphism in autoimmunity, it is im-
portant to clearly identify if the process is related to the
overexpression of C4, which may exacerbate the disease
process through excessive complement activation, or the
underexpression of C4, resulting in impaired immuno-
clearance. There is a high likelihood of overexpression in
one of the C4 isotypes due to the high frequency of trimo-
dular structures and/or homoexpression of C4A or C4B.
In this study, it is found that the relative titers of the
C4A and C4B proteins in a blood plasma sample closely
correspond to the relative C4A and C4B gene dosage in
the same individual. The variation of C4A and C4B pro-
tein titers in the population had been investigated by many
laboratories, using Rg1 and Ch1 mAbs in enzyme-linked
immunosorbent assays (40–42). The overall complement
C4 levels in an individual may be related to the physiologi-
cal state and the status of the RCCX modules. A revisit of
the quantitation of the plasma or serum C4A and C4B lev-
els with respect to the C4 gene dosage will be necessary for
an accurate account of the expression of each C4 gene and
its protein levels in the circulation.
Although in 90.4% of the Caucasian population the dip-
loid genome carries two C4 genes in one of the chromo-
some 6, 55.9% of the same population carries one or three
C4 genes in the other chromosome 6. These trimodular
and monomodular structures increase the continuing likeli-
hood of atypical genetic recombinations or unequal cross-
overs. The misalignments that occur result in disease states
such as CAH where, as with the complement C4 genes,
there is a high sequence homology (98.7%) between
CYP21B and its pseudogene CYP21A. This pseudogene
carries 58 point mutations, 8 mini-insertions and two mini-
deletions in the 5.14-kb sequence that include 59 and 39
flanking regions (43–46). The heterozygosity of a bimodu-
lar RCCX with a monomodular or a trimodular structure
Figure 6. Alignments of the heterozygous RCCX
length variants during meiosis to generate CAH disease
haplotypes (A and B), or to facilitate appropriate pairings
by the mono-S haplotype (C). For A, a pairing of a (trimo-
dular) LLL structure with a mono-L structure may give a
similar result. For C-3, a pairing at the telomeric end may
not allow a correct alignment between the CYP21 genes
from the homologous chromosomes and therefore may re-
duce the exchange of sequences.2194 Gene Dosage of Complement C4A and C4B in Caucasians
is likely to create the interchromosomal pairing of a
CYP21B gene with a CYP21A gene during meiosis (Fig.
6). Exchange of genetic information between the CYP21B
and CYP21A by intergenic recombination may reduce or
abrogate the functionality of the CYP21B gene, depending
on the site and extent of exchanges.
Specifically, the CYP21B gene in the monomodular-
long haplotype (mono-L) would be more vulnerable to
crossover or conversion in heterozygous RCCX individu-
als due to its intrinsic misalignments with the CYP21A in a
bimodular or trimodular chromosome (Fig. 6 A). In this
study, it is found that 20.5% of the salt-losing CAH patients
have mono-L with CYP21A, a phenomenon similar to that
described previously (46). It is also found that 22.7% of the
CAH haplotypes have the CYP21A-CYP21A configura-
tion in bimodular structures. This disease haplotype could
be the result of recombinations between a trimodular chro-
mosome with CYP21A-CYP21A-CYP21B configuration
and a regular bimodular chromosome (at or after the sec-
ond CYP21A gene of the trimodular chromosome; Fig. 6
B). Intriguingly, the mono-S haplotype, which is present in
the normal subjects at a frequency of 11% and common in
the autoimmune disease patients, is totally absent in the
CAH population, suggesting a protective role of this haplo-
type against the disease. The mono-S haplotype probably
enhances the correct CYP21B/CYP21B pairings at the
centromeric end of the MHC among heterozygous RCCX
length variants (Fig. 6, C-1 and C-2) and discourages align-
ments of the RCCX at the telomeric end due to a greater
degree of dissimilarity (Fig. 6 C-3).
The physiological advantage of this new paradigm of ge-
netic diversity created by length polymorphisms is still a
matter of investigation. Although it has not been critically
examined, it is probable that these RCCX length polymor-
phisms may influence the linkage disequilibrium phenome-
non of the HLA class I, II, and III genes (47, 48). In terms
of immune defense, this may be a way to create a variety of
individuals with varying quantities of complement C4A or
C4B proteins, and to homogenize polymorphic sequences
among different C4 genes. It is observed here that there are
slightly more C4 loci coding for C4A isotypes (C4A, 54%;
C4B, 46%), even though 11% of the chromosome 6 are
monomodular with a single C4B gene. This may infer a se-
lection pressure to keep (if not to increase) the frequency of
C4A genes in the population. This could be for greater ef-
ficiency in handling immune complexes, binding to com-
plement receptor CR1, and inhibition of immunoprecipi-
tation, as C4A plays a larger functional role with this regard
than C4B (5, 49).
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